Teladoc Health shares: Why I stay invested despite a 90% loss
According to a report from www.aktienwelt360.de, Teladoc Health shares have seen a dramatic price development recently. Nevertheless, the author of the article believes that the investment in Teladoc Health will pay off in the long term. The US company has struggled in recent years with slow sales growth, high net losses and a questionable acquisition of a stake in Livongo Health. These issues resulted in a significant decline in the value of the stock, primarily attributed to management errors, mispricing of the market, and incorrect growth estimates. Nevertheless, the telemedicine market remains interesting and promising. Telemedicine offers many benefits to consumers, such as...

Teladoc Health shares: Why I stay invested despite a 90% loss
According to a report by www.aktienwelt360.de,
Teladoc Health stock has seen a dramatic price move recently. Nevertheless, the author of the article believes that the investment in Teladoc Health will pay off in the long term. The US company has struggled in recent years with slow sales growth, high net losses and a questionable acquisition of a stake in Livongo Health. These issues resulted in a significant decline in the value of the stock, primarily attributed to management errors, mispricing of the market, and incorrect growth estimates.
Nevertheless, the telemedicine market remains interesting and promising. Telemedicine offers many benefits to consumers, such as reduced wait times and reduced risk of contracting other illnesses in doctor's offices. As a result, the author remains committed to his investment in Teladoc Health despite the current problems and is willing to ride out even large price losses in order to benefit from the long-term potential.
Given current market trends and the long-term outlook, a management change or changes in Teladoc Health's strategic direction may be necessary to restore investor confidence and realize the company's full potential. Nevertheless, the telemedicine market remains promising and the US company is well positioned to benefit from it.
Read the source article at www.aktienwelt360.de